Related Experiment Video
Updated: Jun 4, 2026
05:50
Subcutaneous Neurotrophin 4 Infusion Using Osmotic Pumps or Direct Muscular Injection Enhances Aging Rat Laryngeal Muscles
Published on: June 13, 2017
Botulinum toxin type A for aging face and aesthetic uses
Camile Hexsel1, Doris Hexsel, Manoela Donida Porto
1Department of Dermatology, Henry Ford Hospital, Detroit, Michigan, USA. doris@hexsel.com.br
Dermatologic Therapy
|February 1, 2011
Summary
Botulinum neurotoxin type A injections are a popular cosmetic procedure for reversing aging effects. This article details proper techniques, indications, and managing adverse reactions for aesthetic facial rejuvenation.
Area of Science:
- Cosmetic Dermatology
- Medical Aesthetics
- Neuromodulation
Background:
- Botulinum neurotoxin type A is a widely used injectable for cosmetic enhancement.
- Aging processes manifest physically, leading to demand for minimally invasive rejuvenation.
- Outpatient cosmetic procedures, including neurotoxin injections, are increasingly common.
Purpose of the Study:
- To provide a comprehensive guide on using botulinum neurotoxin type A for aesthetic purposes.
- To detail the techniques, indications, and management of adverse events associated with cosmetic botulinum neurotoxin type A injections.
- To emphasize the importance of careful clinical evaluation and procedural best practices.
Main Methods:
- Review of current clinical practices and literature on botulinum neurotoxin type A.
- Description of pre- and post-procedure recommendations.
- Explanation of product reconstitution, injection techniques, and dosage considerations.
Main Results:
- Botulinum neurotoxin type A effectively addresses various signs of facial aging.
- Proper technique and patient selection are crucial for optimal aesthetic outcomes.
- Adverse reactions are generally mild and manageable with appropriate interventions.
Conclusions:
- Botulinum neurotoxin type A is a valuable tool for facial rejuvenation when administered correctly.
- Understanding indications, techniques, and potential side effects ensures safe and effective treatment.
- This article serves as a practical resource for clinicians performing these popular cosmetic procedures.
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:22Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
01:14Muscles for Facial Expressions
The craniofacial muscles are a collection of approximately 20 thin skeletal muscles situated beneath the skin of the face and scalp. These muscles, primarily responsible for the vast array of human facial expressions, originate from the bones or fibrous structures of the skull and extend outwards to connect with the skin. While most skeletal muscles in the body are enveloped in thick fascia, facial muscles generally have a more delicate fascial covering, with the buccinator muscle being a...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:24Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...